ITMCTR2022000057
Recruiting
Phase 1
Clinical study of Chinese medicine combined with acupoint catgut embedding in treatment of obesity polycystic ovary syndrome
Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(l) It meets the two diagnostic criteria of polycystic ovary syndrome and obesity in western medicine.
- •(2\) It conforms to the syndrome differentiation of traditional Chinese medicine and belongs to the syndrome type of kidney deficiency, liver heat, phlegm and blood stasis.
- •(3\) Between the ages of 18 and 40\.
- •(4\) Volunteer subjects who can persist in treatment for 6 months.
Exclusion Criteria
- •(l) Patients with serious diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, psychosis.
- •(2\) Other diseases that cause abnormal ovulation (Cushing's syndrome, atypical congenital adrenal hyperplasia, ovarian or adrenal tumors, functional hypothalamic amenorrhea, thyroid disease, hyperprolactinemia and early\-onset ovarian insufficiency).
- •(3\) Those who use hormonal and metabolic drugs at the same time to affect the result judgment.
- •(4\) Those who are allergic to the study drug and cannot accept acupuncture stimulation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)ITMCTR2000002997The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Recruiting
Phase 1
Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)novel coronavirus pneumonia (COVID-19)ITMCTR2000003064Affiliated Hospital of Changchun University of traditional Chinese Medicine
Not yet recruiting
Not Applicable
A clinical study of traditional Chinese medicine combined with western medicine in treatment of primary IgA nephropathy (IgAN) in CKD stage 3ITMCTR2200006488Shanghai east hospital (East Hospital affiliated to Tongji University)
Recruiting
Phase 1
Clinical study of the traditional Chinese medicine wenyangtongluo formula combined with toripalimab plus apatinib and tegio as the third line for advanced gastric cancerStomach cancerITMCTR2200005508Department of Oncology of Integrated Traditional Chinese and Western Medicine, High-tech Campus, First Affiliated Hospital of Anhui
Not yet recruiting
Phase 1
A Randomized Controlled Clinical Study for Traditional Chinese Medicine to Improve the Clinical Benefit Rate of Advanced Esophageal CancerEsophageal cancerM8000/3ITMCTR2000003504Henan Province Hospital of TCM